Latest period
$1.34B
YoY change
-7.1%
5Y CAGR
-38.6%
Peak year (2021)
$16.05B
Latest annual
$1.39B
Total Equity history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: $1.39B
Total Equity growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: -7.1%
Total Equity history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | $1.39B | -7.1% | −$105.37M | ||
| 2024 | $1.49B | -35.9% | −$834.99M | ||
| 2023 | $2.33B | +0.8% | +$18.33M | ||
| 2022 | $2.31B | -85.6% | −$13.74B | ||
| 2021 | $16.05B | +1.0% | +$161.95M | ||
| 2020 | $15.88B | +1466.4% | +$14.87B | ||
| 2019 | $1.01B | +0.1% | +$906.00K | ||
| 2018 | $1.01B | +81.3% | +$454.22M | ||
| 2017 | $558.90M | +142.1% | +$328.03M | ||
| 2016 | $230.87M | +29.3% | +$52.31M | ||
| 2015 | $178.56M | +235.5% | +$125.33M | ||
| 2014 | $53.23M | +179.4% | +$34.18M | ||
| 2013 | $19.05M | — | — |
- 2025$1.39B-7.1%
- 2024$1.49B-35.9%
- 2023$2.33B+0.8%
- 2022$2.31B-85.6%
- 2021$16.05B+1.0%
- 2020$15.88B+1466.4%
- 2019$1.01B+0.1%
- 2018$1.01B+81.3%
- 2017$558.90M+142.1%
- 2016$230.87M+29.3%
- 2015$178.56M+235.5%
- 2014$53.23M+179.4%
- 2013$19.05M—
Total Equity values are taken from Teladoc Health's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Teladoc Health (TDOC)
According to Teladoc Health's latest reported financial statements, the company's latest reported total equity is $1.34B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total equity for Teladoc Health (TDOC) came in at $1.39B – declined 7.1% year-over-year.
Over 2020–2025 (5 years), Teladoc Health total equity expanded at a -38.6% compound annual rate, with a net decline across the window.
Teladoc Health total equity peaked at $16.05B in 2021; the latest annual figure is $1.39B in 2025 (91.4% below peak).
2021 marks the peak total equity at $16.05B, with the historical low of $19.05M recorded in 2013.
Teladoc Health Total Equity by Year
Teladoc Health Total Equity 2025: $1.39B
In 2025, Teladoc Health reported total equity of $1.39B, declined 7.1% below 2024.
Teladoc Health Total Equity 2024: $1.49B
Teladoc Health total equity in 2024 was $1.49B, plunged 35.9% below 2023.
Teladoc Health Total Equity 2023: $2.33B
2023's total equity for Teladoc Health came in at $2.33B, edged up 0.8% from 2022.
Teladoc Health Total Equity 2022: $2.31B
Teladoc Health posted total equity of $2.31B in 2022, plunged 85.6% below 2021.
Teladoc Health Total Equity 2021: $16.05B
Teladoc Health total equity in 2021 was $16.05B.
See more financial history for Teladoc Health (TDOC).
Sector peers by Total Equity
Healthcare peers of Teladoc Health (TDOC), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation